aluates Reports

$ 0.0

Automative

Global OTC Drug Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-7Z1974

Global OTC Drug Market Insights and Forecast to 2028

BUY CHAPTERS

Global OTC Drug Market Research Report 2025

Code: QYRE-Auto-7Z1974

Report

January 2025

Pages:99

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer HealthCare

GlaxoSmithKline(GSK )

Johnson & Johnson

Pfizer Inc

Sanofi

Astrazeneca plc

BioGaia

Bristol–Myers Squibb

Bukwang Pharmaceutica

Chr. Hansen

Cipla Ltd

CoLucid

Daiichi Sankyo

Friggs

DSM

Eisai Co Ltd

Eli Lilly

Herbalife

Euradite

OTC Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

OTC Drug Market

The global market for OTC Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Non-prescription drugs refer to drugs that can be purchased for the convenience of the public without a prescription from a physician or other medical professional. The general public can use the drugs on their own discretion according to the drug labels and instructions.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for OTC Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Drug.

The OTC Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global OTC Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the OTC Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of OTC Drug Market Report

Report Metric	Details
Report Name	OTC Drug Market
CAGR	5%
Segment by Type	Class A OTC Drug Class B OTC Drug
Segment by Application	Hospital Clinic Household
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer HealthCare, GlaxoSmithKline(GSK), Johnson&Johnson, Pfizer, Sanofi, AstraZeneca, BioGaia, Bristol Myers Squibb, Bukwang Pharmaceutica, Chr. Hansen, Cipla, CoLucid, Daiichi Sankyo, Friggs, DSM, Eisai, Eli Lilly, Herbalife, Euradite
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the OTC Drug Market report?

Ans: The main players in the OTC Drug Market are Bayer HealthCare, GlaxoSmithKline(GSK), Johnson&Johnson, Pfizer, Sanofi, AstraZeneca, BioGaia, Bristol Myers Squibb, Bukwang Pharmaceutica, Chr. Hansen, Cipla, CoLucid, Daiichi Sankyo, Friggs, DSM, Eisai, Eli Lilly, Herbalife, Euradite

What are the Application segmentation covered in the OTC Drug Market report?

Ans: The Applications covered in the OTC Drug Market report are Hospital, Clinic, Household

What are the Type segmentation covered in the OTC Drug Market report?

Ans: The Types covered in the OTC Drug Market report are Class A OTC Drug, Class B OTC Drug

Recommended Reports

Drug Market Analysis

Pharmacovigilance & Compliance

Pharma Tools & Testing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global OTC Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Class A OTC Drug

1.2.3 Class B OTC Drug

1.3 Market by Application

1.3.1 Global OTC Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Household

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global OTC Drug Market Perspective (2020-2031)

2.2 Global OTC Drug Growth Trends by Region

2.2.1 Global OTC Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 OTC Drug Historic Market Size by Region (2020-2025)

2.2.3 OTC Drug Forecasted Market Size by Region (2026-2031)

2.3 OTC Drug Market Dynamics

2.3.1 OTC Drug Industry Trends

2.3.2 OTC Drug Market Drivers

2.3.3 OTC Drug Market Challenges

2.3.4 OTC Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top OTC Drug Players by Revenue

3.1.1 Global Top OTC Drug Players by Revenue (2020-2025)

3.1.2 Global OTC Drug Revenue Market Share by Players (2020-2025)

3.2 Global OTC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by OTC Drug Revenue

3.4 Global OTC Drug Market Concentration Ratio

3.4.1 Global OTC Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by OTC Drug Revenue in 2024

3.5 Global Key Players of OTC Drug Head office and Area Served

3.6 Global Key Players of OTC Drug, Product and Application

3.7 Global Key Players of OTC Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 OTC Drug Breakdown Data by Type

4.1 Global OTC Drug Historic Market Size by Type (2020-2025)

4.2 Global OTC Drug Forecasted Market Size by Type (2026-2031)

5 OTC Drug Breakdown Data by Application

5.1 Global OTC Drug Historic Market Size by Application (2020-2025)

5.2 Global OTC Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America OTC Drug Market Size (2020-2031)

6.2 North America OTC Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America OTC Drug Market Size by Country (2020-2025)

6.4 North America OTC Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe OTC Drug Market Size (2020-2031)

7.2 Europe OTC Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe OTC Drug Market Size by Country (2020-2025)

7.4 Europe OTC Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific OTC Drug Market Size (2020-2031)

8.2 Asia-Pacific OTC Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific OTC Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific OTC Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America OTC Drug Market Size (2020-2031)

9.2 Latin America OTC Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America OTC Drug Market Size by Country (2020-2025)

9.4 Latin America OTC Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa OTC Drug Market Size (2020-2031)

10.2 Middle East & Africa OTC Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa OTC Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa OTC Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer HealthCare

11.1.1 Bayer HealthCare Company Details

11.1.2 Bayer HealthCare Business Overview

11.1.3 Bayer HealthCare OTC Drug Introduction

11.1.4 Bayer HealthCare Revenue in OTC Drug Business (2020-2025)

11.1.5 Bayer HealthCare Recent Development

11.2 GlaxoSmithKline(GSK)

11.2.1 GlaxoSmithKline(GSK) Company Details

11.2.2 GlaxoSmithKline(GSK) Business Overview

11.2.3 GlaxoSmithKline(GSK) OTC Drug Introduction

11.2.4 GlaxoSmithKline(GSK) Revenue in OTC Drug Business (2020-2025)

11.2.5 GlaxoSmithKline(GSK) Recent Development

11.3 Johnson&Johnson

11.3.1 Johnson&Johnson Company Details

11.3.2 Johnson&Johnson Business Overview

11.3.3 Johnson&Johnson OTC Drug Introduction

11.3.4 Johnson&Johnson Revenue in OTC Drug Business (2020-2025)

11.3.5 Johnson&Johnson Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer OTC Drug Introduction

11.4.4 Pfizer Revenue in OTC Drug Business (2020-2025)

11.4.5 Pfizer Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi OTC Drug Introduction

11.5.4 Sanofi Revenue in OTC Drug Business (2020-2025)

11.5.5 Sanofi Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca OTC Drug Introduction

11.6.4 AstraZeneca Revenue in OTC Drug Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 BioGaia

11.7.1 BioGaia Company Details

11.7.2 BioGaia Business Overview

11.7.3 BioGaia OTC Drug Introduction

11.7.4 BioGaia Revenue in OTC Drug Business (2020-2025)

11.7.5 BioGaia Recent Development

11.8 Bristol Myers Squibb

11.8.1 Bristol Myers Squibb Company Details

11.8.2 Bristol Myers Squibb Business Overview

11.8.3 Bristol Myers Squibb OTC Drug Introduction

11.8.4 Bristol Myers Squibb Revenue in OTC Drug Business (2020-2025)

11.8.5 Bristol Myers Squibb Recent Development

11.9 Bukwang Pharmaceutica

11.9.1 Bukwang Pharmaceutica Company Details

11.9.2 Bukwang Pharmaceutica Business Overview

11.9.3 Bukwang Pharmaceutica OTC Drug Introduction

11.9.4 Bukwang Pharmaceutica Revenue in OTC Drug Business (2020-2025)

11.9.5 Bukwang Pharmaceutica Recent Development

11.10 Chr. Hansen

11.10.1 Chr. Hansen Company Details

11.10.2 Chr. Hansen Business Overview

11.10.3 Chr. Hansen OTC Drug Introduction

11.10.4 Chr. Hansen Revenue in OTC Drug Business (2020-2025)

11.10.5 Chr. Hansen Recent Development

11.11 Cipla

11.11.1 Cipla Company Details

11.11.2 Cipla Business Overview

11.11.3 Cipla OTC Drug Introduction

11.11.4 Cipla Revenue in OTC Drug Business (2020-2025)

11.11.5 Cipla Recent Development

11.12 CoLucid

11.12.1 CoLucid Company Details

11.12.2 CoLucid Business Overview

11.12.3 CoLucid OTC Drug Introduction

11.12.4 CoLucid Revenue in OTC Drug Business (2020-2025)

11.12.5 CoLucid Recent Development

11.13 Daiichi Sankyo

11.13.1 Daiichi Sankyo Company Details

11.13.2 Daiichi Sankyo Business Overview

11.13.3 Daiichi Sankyo OTC Drug Introduction

11.13.4 Daiichi Sankyo Revenue in OTC Drug Business (2020-2025)

11.13.5 Daiichi Sankyo Recent Development

11.14 Friggs

11.14.1 Friggs Company Details

11.14.2 Friggs Business Overview

11.14.3 Friggs OTC Drug Introduction

11.14.4 Friggs Revenue in OTC Drug Business (2020-2025)

11.14.5 Friggs Recent Development

11.15 DSM

11.15.1 DSM Company Details

11.15.2 DSM Business Overview

11.15.3 DSM OTC Drug Introduction

11.15.4 DSM Revenue in OTC Drug Business (2020-2025)

11.15.5 DSM Recent Development

11.16 Eisai

11.16.1 Eisai Company Details

11.16.2 Eisai Business Overview

11.16.3 Eisai OTC Drug Introduction

11.16.4 Eisai Revenue in OTC Drug Business (2020-2025)

11.16.5 Eisai Recent Development

11.17 Eli Lilly

11.17.1 Eli Lilly Company Details

11.17.2 Eli Lilly Business Overview

11.17.3 Eli Lilly OTC Drug Introduction

11.17.4 Eli Lilly Revenue in OTC Drug Business (2020-2025)

11.17.5 Eli Lilly Recent Development

11.18 Herbalife

11.18.1 Herbalife Company Details

11.18.2 Herbalife Business Overview

11.18.3 Herbalife OTC Drug Introduction

11.18.4 Herbalife Revenue in OTC Drug Business (2020-2025)

11.18.5 Herbalife Recent Development

11.19 Euradite

11.19.1 Euradite Company Details

11.19.2 Euradite Business Overview

11.19.3 Euradite OTC Drug Introduction

11.19.4 Euradite Revenue in OTC Drug Business (2020-2025)

11.19.5 Euradite Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bayer HealthCare

GlaxoSmithKline(GSK )

Johnson & Johnson

Pfizer Inc

Sanofi

Astrazeneca plc

BioGaia

Bristol–Myers Squibb

Bukwang Pharmaceutica

Chr. Hansen

Cipla Ltd

CoLucid

Daiichi Sankyo

Friggs

DSM

Eisai Co Ltd

Eli Lilly

Herbalife

Euradite

List of Tables

Table 1. Global OTC Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Class A OTC Drug

Table 3. Key Players of Class B OTC Drug

Table 4. Global OTC Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global OTC Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global OTC Drug Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global OTC Drug Market Share by Region (2020-2025)

Table 8. Global OTC Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global OTC Drug Market Share by Region (2026-2031)

Table 10. OTC Drug Market Trends

Table 11. OTC Drug Market Drivers

Table 12. OTC Drug Market Challenges

Table 13. OTC Drug Market Restraints

Table 14. Global OTC Drug Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global OTC Drug Market Share by Players (2020-2025)

Table 16. Global Top OTC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Drug as of 2024)

Table 17. Ranking of Global Top OTC Drug Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by OTC Drug Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of OTC Drug, Headquarters and Area Served

Table 20. Global Key Players of OTC Drug, Product and Application

Table 21. Global Key Players of OTC Drug, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global OTC Drug Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global OTC Drug Revenue Market Share by Type (2020-2025)

Table 25. Global OTC Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global OTC Drug Revenue Market Share by Type (2026-2031)

Table 27. Global OTC Drug Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global OTC Drug Revenue Market Share by Application (2020-2025)

Table 29. Global OTC Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global OTC Drug Revenue Market Share by Application (2026-2031)

Table 31. North America OTC Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America OTC Drug Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America OTC Drug Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe OTC Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe OTC Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe OTC Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific OTC Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific OTC Drug Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific OTC Drug Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America OTC Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America OTC Drug Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America OTC Drug Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa OTC Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa OTC Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa OTC Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Bayer HealthCare Company Details

Table 47. Bayer HealthCare Business Overview

Table 48. Bayer HealthCare OTC Drug Product

Table 49. Bayer HealthCare Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 50. Bayer HealthCare Recent Development

Table 51. GlaxoSmithKline(GSK) Company Details

Table 52. GlaxoSmithKline(GSK) Business Overview

Table 53. GlaxoSmithKline(GSK) OTC Drug Product

Table 54. GlaxoSmithKline(GSK) Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 55. GlaxoSmithKline(GSK) Recent Development

Table 56. Johnson&Johnson Company Details

Table 57. Johnson&Johnson Business Overview

Table 58. Johnson&Johnson OTC Drug Product

Table 59. Johnson&Johnson Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 60. Johnson&Johnson Recent Development

Table 61. Pfizer Company Details

Table 62. Pfizer Business Overview

Table 63. Pfizer OTC Drug Product

Table 64. Pfizer Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 65. Pfizer Recent Development

Table 66. Sanofi Company Details

Table 67. Sanofi Business Overview

Table 68. Sanofi OTC Drug Product

Table 69. Sanofi Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 70. Sanofi Recent Development

Table 71. AstraZeneca Company Details

Table 72. AstraZeneca Business Overview

Table 73. AstraZeneca OTC Drug Product

Table 74. AstraZeneca Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 75. AstraZeneca Recent Development

Table 76. BioGaia Company Details

Table 77. BioGaia Business Overview

Table 78. BioGaia OTC Drug Product

Table 79. BioGaia Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 80. BioGaia Recent Development

Table 81. Bristol Myers Squibb Company Details

Table 82. Bristol Myers Squibb Business Overview

Table 83. Bristol Myers Squibb OTC Drug Product

Table 84. Bristol Myers Squibb Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 85. Bristol Myers Squibb Recent Development

Table 86. Bukwang Pharmaceutica Company Details

Table 87. Bukwang Pharmaceutica Business Overview

Table 88. Bukwang Pharmaceutica OTC Drug Product

Table 89. Bukwang Pharmaceutica Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 90. Bukwang Pharmaceutica Recent Development

Table 91. Chr. Hansen Company Details

Table 92. Chr. Hansen Business Overview

Table 93. Chr. Hansen OTC Drug Product

Table 94. Chr. Hansen Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 95. Chr. Hansen Recent Development

Table 96. Cipla Company Details

Table 97. Cipla Business Overview

Table 98. Cipla OTC Drug Product

Table 99. Cipla Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 100. Cipla Recent Development

Table 101. CoLucid Company Details

Table 102. CoLucid Business Overview

Table 103. CoLucid OTC Drug Product

Table 104. CoLucid Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 105. CoLucid Recent Development

Table 106. Daiichi Sankyo Company Details

Table 107. Daiichi Sankyo Business Overview

Table 108. Daiichi Sankyo OTC Drug Product

Table 109. Daiichi Sankyo Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 110. Daiichi Sankyo Recent Development

Table 111. Friggs Company Details

Table 112. Friggs Business Overview

Table 113. Friggs OTC Drug Product

Table 114. Friggs Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 115. Friggs Recent Development

Table 116. DSM Company Details

Table 117. DSM Business Overview

Table 118. DSM OTC Drug Product

Table 119. DSM Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 120. DSM Recent Development

Table 121. Eisai Company Details

Table 122. Eisai Business Overview

Table 123. Eisai OTC Drug Product

Table 124. Eisai Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 125. Eisai Recent Development

Table 126. Eli Lilly Company Details

Table 127. Eli Lilly Business Overview

Table 128. Eli Lilly OTC Drug Product

Table 129. Eli Lilly Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 130. Eli Lilly Recent Development

Table 131. Herbalife Company Details

Table 132. Herbalife Business Overview

Table 133. Herbalife OTC Drug Product

Table 134. Herbalife Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 135. Herbalife Recent Development

Table 136. Euradite Company Details

Table 137. Euradite Business Overview

Table 138. Euradite OTC Drug Product

Table 139. Euradite Revenue in OTC Drug Business (2020-2025) & (US$ Million)

Table 140. Euradite Recent Development

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

Table 144. Authors List of This Report

List of Figures

Figure 1. OTC Drug Picture

Figure 2. Global OTC Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global OTC Drug Market Share by Type: 2024 VS 2031

Figure 4. Class A OTC Drug Features

Figure 5. Class B OTC Drug Features

Figure 6. Global OTC Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global OTC Drug Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Household Case Studies

Figure 11. OTC Drug Report Years Considered

Figure 12. Global OTC Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global OTC Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global OTC Drug Market Share by Region: 2024 VS 2031

Figure 15. Global OTC Drug Market Share by Players in 2024

Figure 16. Global Top OTC Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Drug as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by OTC Drug Revenue in 2024

Figure 18. North America OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America OTC Drug Market Share by Country (2020-2031)

Figure 20. United States OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe OTC Drug Market Share by Country (2020-2031)

Figure 24. Germany OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific OTC Drug Market Share by Region (2020-2031)

Figure 32. China OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America OTC Drug Market Share by Country (2020-2031)

Figure 40. Mexico OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa OTC Drug Market Share by Country (2020-2031)

Figure 44. Turkey OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE OTC Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Bayer HealthCare Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 48. GlaxoSmithKline(GSK) Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 49. Johnson&Johnson Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 50. Pfizer Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 51. Sanofi Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 52. AstraZeneca Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 53. BioGaia Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 54. Bristol Myers Squibb Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 55. Bukwang Pharmaceutica Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 56. Chr. Hansen Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 57. Cipla Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 58. CoLucid Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 59. Daiichi Sankyo Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 60. Friggs Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 61. DSM Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 62. Eisai Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 63. Eli Lilly Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 64. Herbalife Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 65. Euradite Revenue Growth Rate in OTC Drug Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global OTC Health Products Market Research Report 2025

Global Over The Counter and OTC Test Market Insights Forecast to 2030

Global OTC Skin Medicine Market Research Report 2024

OTC Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Over The Counter Veterinary Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Over The Counter OTC Pain Relievers Market Research Report 2024

Global OTC Health and Wellness Products Market Research Report 2025

Global OTC Pain Medicines Market Research Report 2024

Global OTC Pain Medications Market Research Report 2024

Global Nonnarcotic Analgesics Market Research Report 2025

OTC Drug and Dietary Supplement Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Insulin Hypoglycemic Drug Market Research Report 2025

Global Over the Counter OTC Drugs Dietary Supplements Market Insights Forecast to 2030

Global OTC Test Device Market Research Report 2024

Global Flavors into Over the Counter OTC Pharmaceuticals Market Insights Forecast to 2030

Global OTC Topical Skin Medicine Market Research Report 2024

Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Over the Counter OTC Analgesics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

OTC Pet Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions